Form 4: RVMD Director Anderson Gifts Shares to Trust
Insider Transaction Report
Revolution Medicines Director Elizabeth M. Anderson reported gifting 15,000 common shares, transferring direct ownership to an irrevocable trust.
Summary
- Elizabeth M. Anderson, a Director of Revolution Medicines, Inc. (RVMD), reported a change in beneficial ownership.
- On March 4, 2026, Anderson disposed of 15,000 shares of common stock directly.
- Concurrently, 15,000 shares of common stock were acquired indirectly through the Irrevocable Deed of Trust of David W. Anderson and Elizabeth M. Anderson.
- Both transactions were reported with a price of $0, indicating a gift or transfer rather than a sale or purchase.
- Following these transactions, Anderson directly owns 8,215 shares, which include 3,142 restricted stock units.
- Indirectly, Anderson beneficially owns 15,000 shares through the Irrevocable Deed of Trust and an additional 26,990 shares through the David W. Anderson 1996 Irrevocable Trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The transaction is a transfer of shares via gift, likely for estate planning, and does not reflect a change in the director's confidence in the company or its operational performance.
Positives
- The transaction represents a planned transfer of shares, potentially for estate planning purposes, rather than an open market sale.
Negatives
- No direct negatives for the company's operations or financial health are indicated by this Form 4.
Risks
- No operational or financial risks for Revolution Medicines, Inc. are disclosed in this Form 4.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding Revolution Medicines, Inc.'s future outlook.
Industry Context
StockSavvy.ai notes that insider transactions, particularly gifts or transfers to trusts, are common for directors and executives for estate planning and wealth management. This specific transaction does not inherently reflect on the operational performance or strategic direction of Revolution Medicines, Inc. or broader industry trends.
Related Party Transactions
- The transfer of shares to the Irrevocable Deed of Trust of David W. Anderson and Elizabeth M. Anderson constitutes a related party transaction, as David W. Anderson is presumably a related individual (e.g., spouse).
- Beneficial ownership is also held through the David W. Anderson 1996 Irrevocable Trust.
Stakeholder Impact
- Shareholders: Minimal direct impact as the total beneficial ownership by the director remains substantial, and the transaction is a transfer, not a sale into the open market.
- Employees, Customers, Suppliers, Creditors: No direct impact from this insider transaction.
Key Dates
| Date | Description |
|---|---|
| 03/04/2026 | Date of reported transaction (disposition and acquisition of shares). |
| 03/06/2026 | Date the Form 4 was signed and filed. |
Keywords
Revolution Medicines, RVMD, Insider Transaction, Form 4, Beneficial Ownership, Director, Stock Gift, Trust Transfer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.